By Julie Steenhuysen CHICAGO (Reuters) - A new type of personalized cancer therapy in which immune cells are harvested from patients' tumors, grown in the lab and infused back into patients showed dramatic results in a small, government-led trial in women with advanced cervical cancer, U.S. researchers said on Monday. Two women in the study who had tumors that had spread throughout their bodies had a complete remission of their cancers after a single treatment, according to the study presented at the American College of Clinical Oncology meeting in Chicago. The trial by researchers at the National Cancer Institute is the first to show that this promising new technology known as adoptive T cell therapy can have an impact in solid tumors, said Dr Renier Brentjens, director of cellular therapeutics at Memorial Sloan Kettering Cancer Center, who was not involved in the study. The approach attempts to take advantage of the body's own T cells — infection-fighting white blood cells that recognize and mount an attack on harmful invaders such as viruses and cancer. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment